HBIOHarvard Bioscience, Inc.

NAS · US · Healthcare · Medical Instruments & Supplies · harvardbioscience.com

7.480USD+5.65%Mkt Cap: 34.05M $P/E: —3d ago

Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services for life science applications in the Americas, Europe, the Middle East, Africa, Asia, and internationally. The company offer…

Industry Peers

Medical Instruments & Supplies

Screen all

ISRG

Intuitive Surgical, Inc.

$135.72BUSDP/E 43.4

EssilorLuxottica Societe anonyme

$81.53BUSDP/E 30.5

BDX

Becton, Dickinson and Company

$52.30BUSDP/E 33.2

MDLN

Medline Inc. Class A Common Stock

West Pharmaceutical Services, Inc.

$24.85BUSDP/E 45.2

DIM

Sartorius Stedim Biotech

$20.46BUSDP/E 64.5

SRT3

Sartorius Aktiengesellschaft

Sartorius Aktiengesellschaft

$14.73BUSDP/E 69.1

SOLV

Solventum Corporation Common Stock

$15.25BUSDP/E 10.9

COO

The Cooper Companies, Inc.

$14.87BUSDP/E 64.6

BAX

Baxter International Inc.

$13.62BUSD

ALGN

Align Technology, Inc.

Key Statistics

Company

Market Cap34.05M $

Enterprise Value72.07M $

Revenue (TTM)87.81M $

Gross Profit49.91M $

Net Income (TTM)-56.70M $

Revenue/Share19.64 USD

Last Price7.480 USD

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees316

CountryUS

SectorHealthcare

IndustryMedical Instruments & Supplies

ISINUS4169061052

Valuation

P/E (Trailing)—

P/E (Forward)11.71

PEG1.31

EV/EBITDA9.78

EV/Revenue0.82

P/S0.39

P/B4.63

EPS (TTM)-2.45

EPS (Forward)0.65

52W Range

3.80066% of range9.400

52W High9.400 USD

52W Low3.800 USD

Profitability

Gross Margin57.67%

Oper. Margin-2.90%

EBITDA Margin8.39%

Profit Margin-65.51%

ROE-412.84%

ROA-70.81%

Growth

Revenue Growth11.10%

Earnings Growth—

Cash Flow & Leverage

Operating CF6.73M $

CapEx (TTM)1.86M $

FCF Margin6.04%

FCF Yield15.58%

Net Debt37.70M $

Net Debt/EBITDA5.12

Balance Sheet

Debt/Equity3.22

Current Ratio1.87

Quick Ratio0.85

Book Value/Sh1.630 USD

Cash/Share1.429 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Splits

Last Split1:10

Split DateMar 16, 2026

Analyst Consensus

Rating2.5 (Hold)

Strong BuyBuyHoldSellStr. Sell

Target (Mean)7.500 USD

Upside (mean)+0.3%

Target Range7.500 USD – 7.500 USD

# Analysts1

Ownership

Shares Out.4.55M

Float3.56M

Insiders9.40%

Institutions43.37%

Short Interest

Short Ratio4.8d

Short % Float1.38%

Short % Out.1.36%

Shares Short61.37K

Short (prev mo.)70.89K

Technical

SMA 506.234 (+20.0%)

SMA 2006.091 (+22.8%)

Beta1.49

S&P 52W Chg18.16%

Avg Vol (30d)14.77K

Avg Vol (10d)30.11K

Technical Indicators

RSI (14)71.5

MACD0.2227

MACD Signal0.1125

MACD Hist.+0.1102

BB Upper7.124 USD

BB Middle6.357 USD

BB Lower5.589 USD

BB Width24.15%

ATR (14)0.3375 USD

Vol Ratio (20d)0.64x